Tierra Biosciences

Tierra Biosciences is pioneering the field of cell-free synthetic biology, revolutionizing protein synthesis through its innovative platform. By leveraging automation, artificial intelligence, and a cell-free system, the company enables rapid, parallel production and expression of diverse DNA variants, breaking traditional barriers in scientific discovery. This approach not only accelerates experimentation but also allows for the synthesis of proteins that are challenging or impossible to produce within living cells. Tierra's platform stands out for its speed, scale, diversity, and flexibility, making it a powerful tool for biopharmaceutical companies, academic researchers, and biotech innovators.

The Tierra Protein Platform facilitates the expression of a wide range of proteins, including those that are toxic or difficult to synthesize in living cells. Users receive custom, purified proteins in as little as three weeks, along with actionable data that supports further scientific exploration. This platform's versatility extends across various fields such as biopharma, synthetic biology, and academic research, enabling unprecedented exploration of biological systems and contributing to a sustainable future.